Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation

被引:40
作者
Kriesel, JD
Gebhardt, BM
Hill, JM
Maulden, SA
Hwang, IP
Clinch, TE
Cao, X
Spruance, SL
Araneo, BA
机构
[1] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84132
[2] UNIV UTAH,MORAN EYE CTR,SALT LAKE CITY,UT 84132
[3] PARADIGM BIOSCI INC,SALT LAKE CITY,UT
[4] LOUISIANA STATE UNIV,CTR EYE,NEW ORLEANS,LA 70112
关键词
D O I
10.1086/513977
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herpes simplex viruses (HSVs) infect epithelial cells, become localized in neurons, and can reactivate in response to a variety of stimuli, including ultraviolet light and hyperthermia, The sequence of gene activation during viral replication is known, but the molecular linkage between exogenous stimuli and HSV reactivation has not been determined, It was hypothesized that interleukin (IL)-6 acts as a signal between exogenous stimuli and neurons, stimulating HSV reactivation from latency. Mouse corneas were infected with HSV-1, and ocular reactivation was induced 5-7 weeks later by thermal stress or corneal exposure to ultraviolet light, Anti-IL-6 monoclonal antibodies were administered to the latently infected mice 8-12 h before the reactivation stimulus, Treatment with anti-IL-6 antibodies resulted in significantly lower frequencies of ocular reactivation compared with those in mice treated with a control immunoglobulin, These results support the hypothesis that IL-6 plays a role in HSV reactivation from latency.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 53 条
[41]  
STARNES HF, 1990, J IMMUNOL, V145, P4185
[42]   POTENTIATION OF TRANSMITTER RELEASE BY CILIARY NEUROTROPHIC FACTOR REQUIRES SOMATIC SIGNALING [J].
STOOP, R ;
POO, MM .
SCIENCE, 1995, 267 (5198) :695-699
[43]   ANTIMURINE IL-6 RECEPTOR ANTIBODY INHIBITS IL-6 EFFECTS INVIVO [J].
SUZUKI, H ;
YASUKAWA, K ;
SAITO, T ;
ANZAI, M ;
GOITSUKA, R ;
HASEGAWA, A ;
OHSUGI, Y ;
TAGA, T ;
KISHIMOTO, T .
IMMUNOLOGY LETTERS, 1991, 30 (01) :17-22
[44]   FUNCTIONAL INHIBITION OF HEMATOPOIETIC AND NEUROTROPHIC CYTOKINES BY BLOCKING THE INTERLEUKIN-6 SIGNAL TRANSDUCER GP130 [J].
TAGA, T ;
NARAZAKI, M ;
YASUKAWA, K ;
SAITO, T ;
MIKI, D ;
HAMAGUCHI, M ;
DAVIS, S ;
SHOYAB, M ;
YANCOPOULOS, GD ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10998-11001
[45]   ULTRAVIOLET-LIGHT INDUCES INCREASED CIRCULATING INTERLEUKIN-6 IN HUMANS [J].
URBANSKI, A ;
SCHWARZ, T ;
NEUNER, P ;
KRUTMANN, J ;
KIRNBAUER, R ;
KOCK, A ;
LUGER, TA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (06) :808-811
[46]  
VANGAMEREN MM, 1994, BLOOD, V84, P1434
[47]   INTERLEUKIN-6 - AN OVERVIEW [J].
VANSNICK, J .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :253-278
[48]  
VARNELL ED, 1995, INVEST OPHTH VIS SCI, V36, P1181
[49]   ENHANCEMENT BY TNF-ALPHA OF REACTIVATION AND REPLICATION OF LATENT HERPES-SIMPLEX VIRUS FROM TRIGEMINAL GANGLIA OF MICE [J].
WALEV, I ;
PODLECH, J ;
FALKE, D .
ARCHIVES OF VIROLOGY, 1995, 140 (06) :987-992
[50]   PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED MALIGNANCIES [J].
WEBER, J ;
YANG, JC ;
TOPALIAN, SL ;
PARKINSON, DR ;
SCHWARTZENTRUBER, DS ;
ETTINGHAUSEN, SE ;
GUNN, H ;
MIXON, A ;
KIM, H ;
COLE, D ;
LEVIN, R ;
ROSENBERG, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :499-506